Accueil   Diary - News   All news Adocia and Lilly report positive Phase 1b topline results

Adocia and Lilly report positive Phase 1b topline results

AAdocia and Lilly report positive Phase 1b topline results on the post-meal effect of ultra-rapid BioChaperone Lispro in patients with type 1 diabetes

 

Adocia and Eli Lilly and Company announced  the completion of a Phase 1b clinical trial evaluating BioChaperone Lispro, an ultra-rapid formulation of insulin lispro licensed to Lilly. This formulation uses Adocia’s proprietary technology BioChaperone, which is designed to accelerate insulin absorption.

 

Read the press release 

 

téléchargementADOCIA-HOME